Lakefront Biotherapeutics NV
GLPGF
$28.08
$0.000.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 06/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -4.16% | 9.06% | -1.22% | -1.22% | -7.16% |
| Total Receivables | -31.42% | -31.51% | -5.18% | -5.18% | -9.13% |
| Inventory | -51.32% | -50.17% | -41.54% | -41.54% | -52.10% |
| Prepaid Expenses | -- | 13.41% | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -86.48% | -92.29% | -33.83% | -33.83% | -4.99% |
| Total Current Assets | -6.59% | 4.58% | -2.65% | -2.65% | -8.13% |
|
|
|||||
| Total Current Assets | -6.59% | 4.58% | -2.65% | -2.65% | -8.13% |
| Net Property, Plant & Equipment | -27.98% | -25.57% | -6.43% | -6.43% | -9.30% |
| Long-term Investments | -- | -- | 8.61% | 8.61% | 0.18% |
| Goodwill | -- | -- | 8.61% | 8.61% | 0.18% |
| Total Other Intangibles | -99.49% | -99.39% | -11.48% | -11.48% | 24.24% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 23.58% | 17.05% | 7.76% | 7.76% | -37.10% |
| Total Assets | -11.15% | -6.59% | -2.46% | -2.46% | -7.61% |
|
|
|||||
| Total Accounts Payable | -39.93% | -42.40% | 13.76% | 13.76% | 16.29% |
| Total Accrued Expenses | -- | -97.92% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -45.34% | -43.64% | -36.40% | -36.40% | -25.68% |
| Total Finance Division Other Current Liabilities | -98.77% | -49.53% | 26.13% | 26.13% | 14.19% |
| Total Other Current Liabilities | -98.77% | -49.53% | 26.13% | 26.13% | 14.19% |
| Total Current Liabilities | -75.65% | -48.26% | 21.08% | 21.08% | 14.56% |
|
|
|||||
| Total Current Liabilities | -75.65% | -48.26% | 21.08% | 21.08% | 14.56% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -33.99% | -28.65% | -1.75% | -1.75% | 103.32% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -98.24% | -98.40% | -16.82% | -16.82% | -23.10% |
| Total Liabilities | -90.10% | -84.38% | -6.73% | -6.73% | -12.96% |
|
|
|||||
| Common Stock & APIC | 5.97% | 11.12% | 9.61% | 9.61% | 0.18% |
| Retained Earnings | 186.16% | 277.81% | -251.17% | -251.17% | -111.40% |
| Treasury Stock & Other | -180.78% | 89.72% | -288.05% | -288.05% | 21.63% |
| Total Common Equity | 25.46% | 26.68% | -0.43% | -0.43% | -4.91% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 25.46% | 26.68% | -0.43% | -0.43% | -4.91% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 25.46% | 26.68% | -0.43% | -0.43% | -4.91% |
|
|
|||||